153 related articles for article (PubMed ID: 35772685)
21. SERPINA1 Z allele is associated with cystic fibrosis liver disease.
Boëlle PY; Debray D; Guillot L; Corvol H;
Genet Med; 2019 Sep; 21(9):2151-2155. PubMed ID: 30739910
[TBL] [Abstract][Full Text] [Related]
22. Liver disease in adult patients with cystic fibrosis: a frequent and independent prognostic factor associated with death or lung transplantation.
Chryssostalis A; Hubert D; Coste J; Kanaan R; Burgel PR; Desmazes-Dufeu N; Soubrane O; Dusser D; Sogni P
J Hepatol; 2011 Dec; 55(6):1377-82. PubMed ID: 21703187
[TBL] [Abstract][Full Text] [Related]
23. Correlation of Transient Elastography With Severity of Cystic Fibrosis-related Liver Disease.
Aqul A; Jonas MM; Harney S; Raza R; Sawicki GS; Mitchell PD; Fawaz R
J Pediatr Gastroenterol Nutr; 2017 Apr; 64(4):505-511. PubMed ID: 27782957
[TBL] [Abstract][Full Text] [Related]
24. Cystic fibrosis-related liver disease is an independent risk factor for mortality and increased health care resource utilization in hospitalized pediatric patients with cystic fibrosis.
Thavamani A; Umapathi KK; Kutney K; Sferra TJ; Sankararaman S
Pediatr Pulmonol; 2022 Jul; 57(7):1717-1725. PubMed ID: 35499220
[TBL] [Abstract][Full Text] [Related]
25. The impact of liver disease on mortality in cystic fibrosis-A systematic review.
Sasame A; Stokes D; Bourke B; Connolly L; Fitzpatrick E; Rowland M
J Cyst Fibros; 2022 Mar; 21(2):202-211. PubMed ID: 34380590
[TBL] [Abstract][Full Text] [Related]
26. Long-term follow-up and liver outcomes in children with cystic fibrosis and nodular liver on ultrasound in a multi-center study.
Leung DH; Ye W; Schwarzenberg SJ; Freeman AJ; Palermo JJ; Weymann A; Alonso EM; Karnsakul WW; Murray KF; Stoll JM; Huang S; Karmazyn B; Masand P; Magee JC; Alazraki AL; Towbin AJ; Nicholas JL; Green N; Otto RK; Siegel MJ; Ling SC; Navarro OM; Harned RK; Narkewicz MR; Molleston JP;
J Cyst Fibros; 2023 Mar; 22(2):248-255. PubMed ID: 35985930
[TBL] [Abstract][Full Text] [Related]
27. Aspartate aminotransferase to platelet ratio and fibrosis-4 as biomarkers in biopsy-validated pediatric cystic fibrosis liver disease.
Leung DH; Khan M; Minard CG; Guffey D; Ramm LE; Clouston AD; Miller G; Lewindon PJ; Shepherd RW; Ramm GA
Hepatology; 2015 Nov; 62(5):1576-83. PubMed ID: 26223427
[TBL] [Abstract][Full Text] [Related]
28. Outcomes of patients with cystic fibrosis undergoing lung transplantation with and without cystic fibrosis-associated liver cirrhosis.
Nash EF; Volling C; Gutierrez CA; Tullis E; Coonar A; McRae K; Keshavjee S; Singer LG; Durie PR; Chaparro C
Clin Transplant; 2012; 26(1):34-41. PubMed ID: 21272072
[TBL] [Abstract][Full Text] [Related]
29. Cystic fibrosis-related liver disease: Clinical presentations, diagnostic and monitoring approaches in the era of CFTR modulator therapies.
Dana J; Debray D; Beaufrère A; Hillaire S; Fabre M; Reinhold C; Baumert TF; Berteloot L; Vilgrain V
J Hepatol; 2022 Feb; 76(2):420-434. PubMed ID: 34678405
[TBL] [Abstract][Full Text] [Related]
30. Longitudinal Transient Elastography Measurements Used in Follow-up for Patients with Cystic Fibrosis.
Van Biervliet S; Verdievel H; Vande Velde S; De Bruyne R; De Looze D; Verhelst X; Geerts A; Robberecht E; Van Vlierberghe H
Ultrasound Med Biol; 2016 Apr; 42(4):848-54. PubMed ID: 26806442
[TBL] [Abstract][Full Text] [Related]
31. Supersonic shear-wave elastography and APRI for the detection and staging of liver disease in pediatric cystic fibrosis.
Calvopina DA; Noble C; Weis A; Hartel GF; Ramm LE; Balouch F; Fernandez-Rojo MA; Coleman MA; Lewindon PJ; Ramm GA
J Cyst Fibros; 2020 May; 19(3):449-454. PubMed ID: 31303380
[TBL] [Abstract][Full Text] [Related]
32. Cystic Fibrosis Liver Disease: Outcomes and Risk Factors in a Large Cohort of French Patients.
Boëlle PY; Debray D; Guillot L; Clement A; Corvol H;
Hepatology; 2019 Apr; 69(4):1648-1656. PubMed ID: 30058245
[TBL] [Abstract][Full Text] [Related]
33. Serum proteome profiling identifies novel and powerful markers of cystic fibrosis liver disease.
Rath T; Hage L; Kügler M; Menendez Menendez K; Zachoval R; Naehrlich L; Schulz R; Roderfeld M; Roeb E
PLoS One; 2013; 8(3):e58955. PubMed ID: 23516586
[TBL] [Abstract][Full Text] [Related]
34. Review article: epidemiology, pathogenesis and management of liver disease in adults with cystic fibrosis.
Scott J; Jones AM; Piper Hanley K; Athwal VS
Aliment Pharmacol Ther; 2022 Feb; 55(4):389-400. PubMed ID: 35048397
[TBL] [Abstract][Full Text] [Related]
35. Diagnosis, follow-up and treatment of cystic fibrosis-related liver disease.
van de Peppel IP; Bertolini A; Jonker JW; Bodewes FAJA; Verkade HJ
Curr Opin Pulm Med; 2017 Nov; 23(6):562-569. PubMed ID: 28837442
[TBL] [Abstract][Full Text] [Related]
36. The emerging burden of liver disease in cystic fibrosis patients: A UK nationwide study.
Toledano MB; Mukherjee SK; Howell J; Westaby D; Khan SA; Bilton D; Simmonds NJ
PLoS One; 2019; 14(4):e0212779. PubMed ID: 30947265
[TBL] [Abstract][Full Text] [Related]
37. Cystic fibrosis liver disease in Newfoundland and Labrador: a prevalence study.
Squirell E; Lockyer J
Can Liver J; 2021; 4(1):33-37. PubMed ID: 35991469
[TBL] [Abstract][Full Text] [Related]
38. Towards a Standardized Classification of the Hepatobiliary Manifestations in Cystic Fibrosis (CFHBI): A Joint ESPGHAN/NASPGHAN Position Paper.
Bodewes FAJA; Freeman AJ; Weymann A; Debray D; Scheers I; Verkade HJ; Narkewicz MR
J Pediatr Gastroenterol Nutr; 2024 Jan; 78(1):153-165. PubMed ID: 38291686
[TBL] [Abstract][Full Text] [Related]
39. Cystic fibrosis liver disease - from diagnosis to risk factors.
Ciucă IM; Pop L; Tămaş L; Tăban S
Rom J Morphol Embryol; 2014; 55(1):91-5. PubMed ID: 24715171
[TBL] [Abstract][Full Text] [Related]
40. Non-invasive liver elastography (Fibroscan) for detection of cystic fibrosis-associated liver disease.
Witters P; De Boeck K; Dupont L; Proesmans M; Vermeulen F; Servaes R; Verslype C; Laleman W; Nevens F; Hoffman I; Cassiman D
J Cyst Fibros; 2009 Dec; 8(6):392-9. PubMed ID: 19733131
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
